Literature DB >> 17392162

Novel roles of local insulin-like growth factor-1 activation in gastric ulcer healing: promotes actin polymerization, cell proliferation, re-epithelialization, and induces cyclooxygenase-2 in a phosphatidylinositol 3-kinase-dependent manner.

Tom Nguyen1, Jianyuan Chai, Aihua Li, Tomohiko Akahoshi, Tetsuya Tanigawa, Andrzej S Tarnawski.   

Abstract

The precise role of insulin-like growth factor (IGF)-1 in gastric ulcer healing is unknown. In experimental rat gastric ulcers, we examined expression of IGF-1 mRNA and protein by reverse transcriptase-polymerase chain reaction or enzyme-linked immunosorbent assay and immunostaining, respectively. In cultured rat gastric epithelial RGM1 cells, we examined effects of exogenous IGF-1 on cell migration, re-epithelialization, and proliferation-essential components of ulcer healing. We also examined whether IGF-1 induces cyclooxygenase (COX)-2 expression and determined the role of phosphatidylinositol 3-kinase and mitogen-activated protein kinase signaling pathways in mediating IGF-1 actions. Gastric ulceration triggered an approximately threefold increase in IGF-1 expression in epithelial cells of the ulcer margins (P < 0.001 versus control), especially in cells re-epithelizing granulation tissue and in mucosa in proximity to the ulcer margin. Treatment of RGM1 cells with IGF-1 caused a dramatic increase in actin polymerization, an eightfold increase in cell migration (P < 0.001), a 195% increase in cell proliferation (P < 0.05), and a sixfold increase in COX-2 expression (P < 0.01). Inhibitor of phosphatidylinositol 3-kinase abolished IGF-1-induced RGM1 cell migration and proliferation, actin polymerization, and COX-2 expression. The up-regulation of IGF-1 in gastric ulcer margin accelerates gastric ulcer healing by promoting cell re-epithelization, proliferation, and COX-2 expression via the phosphatidylinositol 3-kinase pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392162      PMCID: PMC1829456          DOI: 10.2353/ajpath.2007.060745

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

Review 1.  The multifunctional role of IGF-1 in peripheral nerve regeneration.

Authors:  Eric D Rabinovsky
Journal:  Neurol Res       Date:  2004-03       Impact factor: 2.448

2.  Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor.

Authors:  M D Basson; I M Modlin; J A Madri
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 3.  Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives.

Authors:  F Halter; A S Tarnawski; A Schmassmann; B M Peskar
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

Review 4.  Gastrointestinal mucosal regeneration: role of growth factors.

Authors:  M K Jones; M Tomikawa; B Mohajer; A S Tarnawski
Journal:  Front Biosci       Date:  1999-03-15

5.  Insulin-like growth factor I in human gastrointestinal exocrine secretions.

Authors:  O P Chaurasia; S P Marcuard; E R Seidel
Journal:  Regul Pept       Date:  1994-02-24

6.  Interaction of hepatocyte growth factor and non-steroidal anti-inflammatory drugs during gastric epithelial wound healing.

Authors:  Peter Netzer; Fred Halter; Thomas Y Ma; Neil Hoa; Nathan Nguyen; Toshikazu Nakamura; Andrzej S Tarnawski
Journal:  Digestion       Date:  2003       Impact factor: 3.216

7.  Induction of cyclooxygenase-2 in a rat gastric epithelial cell line by epiregulin and basic fibroblast growth factor.

Authors:  E Sasaki; R Pai; F Halter; T Komurasaki; T Arakawa; K Kobayashi; T Kuroki; A S Tarnawski
Journal:  J Clin Gastroenterol       Date:  1998       Impact factor: 3.062

8.  COX-2 is essential for EGF induction of cell proliferation in gastric RGM1 cells.

Authors:  Eiji Sasaki; Kazunari Tominaga; Toshio Watanabe; Yasuhiro Fujiwara; Nobuhide Oshitani; Takayuki Matsumoto; Kazuhide Higuchi; A S Tarnawski; Tetsuo Arakawa
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

9.  Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.

Authors:  Meng Qiao; Paul Shapiro; Rakesh Kumar; Antonino Passaniti
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

10.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01
View more
  10 in total

1.  Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands.

Authors:  Jie Tian; Isabel Lambertz; Thomas R Berton; Joyce E Rundhaug; Kaoru Kiguchi; Stephanie H Shirley; John Digiovanni; Claudio J Conti; Susan M Fischer; Robin Fuchs-Young
Journal:  Mol Carcinog       Date:  2011-10-17       Impact factor: 4.784

2.  EGFR is involved in control of gastric cell proliferation through activation of MAPK and Src signalling pathways in early-weaned rats.

Authors:  L H Osaki; P M Figueiredo; E P Alvares; P Gama
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

3.  NSAID-induced injury of gastric epithelial cells is reversible: roles of mitochondria, AMP kinase, NGF, and PGE2.

Authors:  Amrita Ahluwalia; Neil Hoa; Michael K Jones; Andrzej S Tarnawski
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

4.  Strain-induced proliferation requires the phosphatidylinositol 3-kinase/AKT/glycogen synthase kinase pathway.

Authors:  Christopher P Gayer; Lakshmi S Chaturvedi; Shouye Wang; David H Craig; Thomas Flanigan; Marc D Basson
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

5.  Loss of MLK3 signaling impedes ulcer healing by modulating MAPK signaling in mouse intestinal mucosa.

Authors:  Pavlo L Kovalenko; Lyudmyla Kunovska; Jian Chen; Kathleen A Gallo; Marc D Basson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-23       Impact factor: 4.052

6.  Carbon monoxide released from its pharmacological donor, tricarbonyldichlororuthenium (II) dimer, accelerates the healing of pre-existing gastric ulcers.

Authors:  Marcin Magierowski; Katarzyna Magierowska; Magdalena Hubalewska-Mazgaj; Zbigniew Sliwowski; Grzegorz Ginter; Robert Pajdo; Anna Chmura; Slawomir Kwiecien; Tomasz Brzozowski
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

7.  Analysis of candidate biomarkers and related transcription factors involved in the development and restoration of stress-induced gastric ulcer by transcriptomics.

Authors:  Pan Huang; Weihong Tang; Rong Shen; Xiaoli Ju; Genbao Shao; Xiao Xu; Anqi Jiang; Xiaobin Qian; Miao Chen; Zhengrong Zhou; Caifang Ren
Journal:  Cell Stress Chaperones       Date:  2020-02-22       Impact factor: 3.667

8.  Cell injury triggers actin polymerization to initiate epithelial restitution.

Authors:  Eitaro Aihara; Neisha M Medina-Candelaria; Hikaru Hanyu; Andrea L Matthis; Kristen A Engevik; Christine B Gurniak; Walter Witke; Jerrold R Turner; Tongli Zhang; Marshall H Montrose
Journal:  J Cell Sci       Date:  2018-08-20       Impact factor: 5.285

9.  Effects of the IGF-1/PTEN/Akt/FoxO signaling pathway on male reproduction in rats subjected to water immersion and restraint stress.

Authors:  Pan Huang; Zhengrong Zhou; Fangxiong Shi; Genbao Shao; Ran Wang; Jintian Wang; Kangxin Wang; Wei Ding
Journal:  Mol Med Rep       Date:  2016-10-24       Impact factor: 2.952

10.  Na+ /H+ exchanger NHE1 and NHE2 have opposite effects on migration velocity in rat gastric surface cells.

Authors:  Anja Paehler Vor der Nolte; Giriprakash Chodisetti; Zhenglin Yuan; Florian Busch; Brigitte Riederer; Min Luo; Yan Yu; Manoj B Menon; Andreas Schneider; Renata Stripecke; Katerina Nikolovska; Sunil Yeruva; Ursula Seidler
Journal:  J Cell Physiol       Date:  2017-02-21       Impact factor: 6.384

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.